Isaac Veinbergs, Ph.D. - Publications

Affiliations: 
University of California, San Diego, La Jolla, CA 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=7

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Vanover KE, Veinbergs I, Davis RE. Antipsychotic-like behavioral effects and cognitive enhancement by a potent and selective muscarinic M-sub-1 receptor agonist, AC-260584. Behavioral Neuroscience. 122: 570-5. PMID 18513127 DOI: 10.1037/0735-7044.122.3.570  1
2007 Gardell LR, Vanover KE, Pounds L, Johnson RW, Barido R, Anderson GT, Veinbergs I, Dyssegaard A, Brunmark P, Tabatabaei A, Davis RE, Brann MR, Hacksell U, Bonhaus DW. ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models. The Journal of Pharmacology and Experimental Therapeutics. 322: 862-70. PMID 17519387 DOI: 10.1124/jpet.107.121715  1
2006 Vanover KE, Weiner DM, Makhay M, Veinbergs I, Gardell LR, Lameh J, Del Tredici AL, Piu F, Schiffer HH, Ott TR, Burstein ES, Uldam AK, Thygesen MB, Schlienger N, Andersson CM, et al. Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist. The Journal of Pharmacology and Experimental Therapeutics. 317: 910-8. PMID 16469866 DOI: 10.1124/jpet.105.097006  1
2004 Weiner DM, Meltzer HY, Veinbergs I, Donohue EM, Spalding TA, Smith TT, Mohell N, Harvey SC, Lameh J, Nash N, Vanover KE, Olsson R, Jayathilake K, Lee M, Levey AI, et al. The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine. Psychopharmacology. 177: 207-16. PMID 15258717 DOI: 10.1007/s00213-004-1940-5  1
2004 Vanover KE, Harvey SC, Son T, Bradley SR, Kold H, Makhay M, Veinbergs I, Spalding TA, Weiner DM, Andersson CM, Tolf BR, Brann MR, Hacksell U, Davis RE. Pharmacological characterization of AC-90179 [2-(4-methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide hydrochloride]: a selective serotonin 2A receptor inverse agonist. The Journal of Pharmacology and Experimental Therapeutics. 310: 943-51. PMID 15102927 DOI: 10.1124/jpet.104.066688  1
2002 Van Uden E, Mallory M, Veinbergs I, Alford M, Rockenstein E, Masliah E. Increased extracellular amyloid deposition and neurodegeneration in human amyloid precursor protein transgenic mice deficient in receptor-associated protein. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 9298-304. PMID 12417655  1
2002 Veinbergs I, Everson A, Sagara Y, Masliah E. Neurotoxic effects of apolipoprotein E4 are mediated via dysregulation of calcium homeostasis. Journal of Neuroscience Research. 67: 379-87. PMID 11813243 DOI: 10.1002/jnr.10138  1
2001 Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L. beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. 98: 12245-50. PMID 11572944 DOI: 10.1073/pnas.211412398  1
2001 Veinbergs I, Van Uden E, Mallory M, Alford M, McGiffert C, DeTeresa R, Orlando R, Masliah E. Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E. Experimental Neurology. 170: 15-26. PMID 11421580 DOI: 10.1006/exnr.2001.7684  1
2000 Veinbergs I, Mallory M, Sagara Y, Masliah E. Vitamin E supplementation prevents spatial learning deficits and dendritic alterations in aged apolipoprotein E-deficient mice. The European Journal of Neuroscience. 12: 4541-6. PMID 11122365 DOI: 10.1046/j.1460-9568.2000.01308.x  1
2000 Veinbergs I, Mante M, Mallory M, Masliah E. Neurotrophic effects of Cerebrolysin in animal models of excitotoxicity. Journal of Neural Transmission. Supplementum. 59: 273-80. PMID 10961439  1
2000 Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science (New York, N.Y.). 287: 1265-9. PMID 10678833 DOI: 10.1126/science.287.5456.1265  1
1999 Licastro F, Campbell IL, Kincaid C, Veinbergs I, Van Uden E, Rockenstein E, Mallory M, Gilbert JR, Masliah E. A role for apoE in regulating the levels of alpha-1-antichymotrypsin in the aging mouse brain and in Alzheimer's disease. The American Journal of Pathology. 155: 869-75. PMID 10487844  1
1999 Veinbergs I, Mante M, Jung MW, Van Uden E, Masliah E. Synaptotagmin and synaptic transmission alterations in apolipoprotein E-deficient mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 23: 519-31. PMID 10378234 DOI: 10.1016/S0278-5846(99)00013-5  1
1999 Van Uden E, Veinbergs I, Mallory M, Orlando R, Masliah E. A novel role for receptor-associated protein in somatostatin modulation: implications for Alzheimer's disease. Neuroscience. 88: 687-700. PMID 10363810 DOI: 10.1016/S0306-4522(98)00272-3  1
1999 Veinbergs I, Masliah E. Synaptic alterations in apolipoprotein E knockout mice. Neuroscience. 91: 401-3. PMID 10336088 DOI: 10.1016/S0306-4522(98)00602-2  1
1999 Veinbergs I, Mallory M, Mante M, Rockenstein E, Gilbert JR, Masliah E. Differential neurotrophic effects of apolipoprotein E in aged transgenic mice. Neuroscience Letters. 265: 218-22. PMID 10327170 DOI: 10.1016/S0304-3940(99)00243-8  1
1999 Masliah E, Armasolo F, Veinbergs I, Mallory M, Samuel W. Cerebrolysin ameliorates performance deficits, and neuronal damage in apolipoprotein E-deficient mice. Pharmacology, Biochemistry, and Behavior. 62: 239-45. PMID 9972690 DOI: 10.1016/S0091-3057(98)00144-0  1
1998 Veinbergs I, Jung MW, Young SJ, Van Uden E, Groves PM, Masliah E. Altered long-term potentiation in the hippocampus of apolipoprotein E-deficient mice. Neuroscience Letters. 249: 71-4. PMID 9682819 DOI: 10.1016/S0304-3940(98)00399-1  1
1998 Hsu LJ, Mallory M, Xia Y, Veinbergs I, Hashimoto M, Yoshimoto M, Thal LJ, Saitoh T, Masliah E. Expression pattern of synucleins (non-Abeta component of Alzheimer's disease amyloid precursor protein/alpha-synuclein) during murine brain development. Journal of Neurochemistry. 71: 338-44. PMID 9648883  1
1997 Masliah E, Samuel W, Veinbergs I, Mallory M, Mante M, Saitoh T. Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. Brain Research. 751: 307-14. PMID 9099820 DOI: 10.1016/S0006-8993(96)01420-5  1
1996 Masliah E, Mallory M, Veinbergs I, Miller A, Samuel W. Alterations in apolipoprotein E expression during aging and neurodegeneration. Progress in Neurobiology. 50: 493-503. PMID 9015824 DOI: 10.1016/S0301-0082(96)00038-X  1
1995 Masliah E, Mallory M, Ge N, Alford M, Veinbergs I, Roses AD. Neurodegeneration in the central nervous system of apoE-deficient mice. Experimental Neurology. 136: 107-22. PMID 7498401 DOI: 10.1006/exnr.1995.1088  1
1994 Roch JM, Masliah E, Roch-Levecq AC, Sundsmo MP, Otero DA, Veinbergs I, Saitoh T. Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor. Proceedings of the National Academy of Sciences of the United States of America. 91: 7450-4. PMID 8052602 DOI: 10.1073/pnas.91.16.7450  1
Show low-probability matches.